​

Funding Round

Series C - Orchard Therapeutics

Series C - Orchard Therapeutics

Investment Firm

Overview

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Announced Date

Aug 13, 2018

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

12

Investor Name
Participant InvestorRA Capital Management
Participant InvestorForesite Capital
Participant InvestorTemasek Holdings
Participant InvestorBaillie Gifford
Participant InvestorVenrock

Round Details and Background

Orchard Therapeutics raised $150000000 on 2018-08-13 in Series C

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 05, 2021
Post-IPO Equity - Orchard Therapeutics
5-150.0M
Mar 06, 2023
Post-IPO Equity - Orchard Therapeutics
5-34.0M
Nov 23, 2016
Grant - Orchard Therapeutics
1-20.0M
May 03, 2016
Series A - Orchard Therapeutics
3-30.5M

Recent Activity

There is no recent news or activity for this profile.